160
Views
1
CrossRef citations to date
0
Altmetric
REVIEW

Progress in Research on Biomarkers of Gestational Diabetes Mellitus and Preeclampsia

, , & ORCID Icon
Pages 3807-3815 | Received 24 Aug 2023, Accepted 31 Oct 2023, Published online: 21 Nov 2023

References

  • Choudhury AA, Devi Rajeswari V. Gestational diabetes mellitus - A metabolic and reproductive disorder. Biomed Pharmacother. 2021;143:112183. doi:10.1016/j.biopha.2021.112183
  • Yu W, Wu N, Li L, OuYang H, Qian M, Shen H. A review of research progress on glycemic variability and gestational diabetes. Diabetes Metabol Syndr Obes. 2020;13:2729–2741. doi:10.2147/DMSO.S261486
  • Devarshi PA-O, Grant RA-O, Ikonte CJ, Hazels Mitmesser S. Maternal Omega-3 nutrition, placental transfer and fetal brain development in gestational diabetes and preeclampsia. Nutrients. 2019;11(5):1107. doi:10.3390/nu11051107
  • Di Cianni G, Miccoli R, Fau - Volpe L, Lencioni C, Del Prato S. Intermediate metabolism in normal pregnancy and in gestational diabetes. Diabetes Metab Res Rev. 2003;19(4):259–270. doi:10.1002/dmrr.390
  • Chen HT, Deng SQ, Li ZY, et al. 广东地区15家医院孕前糖尿病的调查研究 [Investigation of pregestational diabetes mellitus in 15 hospitals in Guangdong province]. Zhonghua fu Chan ke za zhi. 2017;52(7):436–442. Chinese.
  • Casagrande SS, Linder B, Cowie CC. Prevalence of gestational diabetes and subsequent Type 2 diabetes among U.S. women. Diabetes Res Clin Pract. 2018;141:200–208. doi:10.1016/j.diabres.2018.05.010
  • Gao C, Sun XA-O, Lu L, Liu F, Yuan J. Prevalence of gestational diabetes mellitus in mainland China: a systematic review and meta-analysis. J Diabetes Investig. 2019;10(1):154–162. doi:10.1111/jdi.12854
  • Nakashima A, Shima T, Tsuda S, et al. Disruption of Placental Homeostasis Leads to Preeclampsia. Int J Mol Sci. 2020;21(9):3298. doi:10.3390/ijms21093298
  • Guney G, Taskin MI, Tokmak A. Increase of circulating inflammatory molecules in preeclampsia, an update. Eur Cytokine Netw. 2020;31(1):18–31. doi:10.1684/ecn.2020.0443
  • Valenzuela FJ, Pérez-Sepúlveda A, Torres MJ, Correa P, Repetto GM, Illanes SE. Pathogenesis of preeclampsia: the genetic component. J Pregnancy. 2012;2012:1–8. doi:10.1155/2012/632732
  • Ives CW, Sinkey R, Rajapreyar I, Tita ATN, Oparil S. Preeclampsia-pathophysiology and clinical presentations: JACC State-of-the-Art Review. J Am Coll Cardiol. 2020;76(14):1690–1702.
  • Yang Y, Wu N. Gestational diabetes mellitus and preeclampsia: correlation and influencing factors. Front Cardiovasc Med. 2022;9. doi:10.3389/fcvm.2022.831297
  • Ostlund I, Haglund B, Hanson U. Gestational diabetes and preeclampsia. Eur J Obstet Gynecol Reprod Biol. 2004;113(1):12–16. doi:10.1016/j.ejogrb.2003.07.001
  • Lewandowska MA-O, Więckowska B, Sajdak S. Pre-pregnancy obesity, excessive gestational weight gain, and the risk of pregnancy-induced hypertension and gestational diabetes mellitus. J Clin Med. 2020;9(6):1980. doi:10.3390/jcm9061980
  • Hillier TA, Pedula KL, Ogasawara KK, Vesco KK, Oshiro C, Van Marter JL. Impact of earlier gestational diabetes screening for pregnant people with obesity on maternal and perinatal outcomes. J Perinat Med. 2022;50(8):1036–1044. doi:10.1515/jpm-2021-0581
  • Ke JF, Liu S, Ge RL, Ma L, Li MF. Associations of maternal pre-pregnancy BMI and gestational weight gain with the risks of adverse pregnancy outcomes in Chinese women with gestational diabetes mellitus. BMC Pregnancy Childbirth. 2023;23(1). doi:10.1186/s12884-023-05657-8
  • Ferrari NA-O, Joisten C. Impact of physical activity on course and outcome of pregnancy from pre- to postnatal. Eur J Clin Nutr. 2021;75(12):1698–1709. doi:10.1038/s41430-021-00904-7
  • Chen P, Wang S, Fau - Ji J, et al. Risk factors and management of gestational diabetes. Cell Biochem Biophys. 2015;71(2):689–694. doi:10.1007/s12013-014-0248-2
  • Han WA-O, Yang SA-O, Xiao H, et al. Role of adiponectin in cardiovascular diseases related to glucose and lipid metabolism disorders. Int J Mol Sci. 2022;23(24):15627.
  • Moyce Gruber BL, Dolinsky VA-O. The role of adiponectin during pregnancy and gestational diabetes. Life. 2023;13(2):301. doi:10.3390/life13020301
  • Boyadzhieva M, Atanasova I, Fau - Zacharieva S, Zacharieva S, Fau - Kedikova S, Kedikova S. Adipocytokines during pregnancy and postpartum in women with gestational diabetes and healthy controls. J Endocrinol Investigat. 2013;36:944–949.
  • Salem MM, Sokary AAE, Hazzaa SM, Gharib MNE. Predictive value of first trimester measurement of adiponectin and 1,5 anhydroglucitol in diagnosis of gestational diabetes mellitus. J Adv Med Med Res. 2020;111–118. doi:10.9734/jammr/2020/v32i2430758
  • Xu J, Zhao YH, Chen YP, et al. Maternal circulating concentrations of tumor necrosis factor-alpha, leptin, and adiponectin in gestational diabetes mellitus: a systematic review and meta-analysis. Sci World J. 2014;2014:1–12. doi:10.1155/2014/926932
  • Sweeting AN, Wong J, Appelblom H, et al. A novel early pregnancy risk prediction model for gestational diabetes mellitus. Fetal Diagn Ther. 2019;45(2):76–84. doi:10.1159/000486853
  • Fang H, Judd RL. Adiponectin regulation and function. Comprehens Physiol. 2011;8(3):1031–1063.
  • Yun-Hui D, Ma XL. 脂联素减轻糖尿病血管内皮损伤的保护机制 [Mechanisms of adiponectin protection against diabetes-induced vascular endothelial injury]. Sheng Li Xue Bao. 2019;71(3):485–490. Chinese.
  • Yadav A, Kataria V, Saini V, Yadav A. Role of leptin and adiponectin in insulin resistance. Clin Chim Acta. 2013;417:80–84. doi:10.1016/j.cca.2012.12.007
  • Yang M, Peng S, Li W, Wan Z, Fan L, Du Y. Relationships between plasma leptin levels, leptin G2548A, leptin receptor Gln223Arg polymorphisms and gestational diabetes mellitus in Chinese population. Sci Rep. 2016;6(1). doi:10.1038/srep23948
  • Plowden TC, Zarek SM, Rafique S, et al. Preconception leptin levels and pregnancy outcomes: a prospective cohort study. Obes Sci Pract. 2020;6(2):181–188. doi:10.1002/osp4.399
  • Xiao W-Q, He J-R, Shen S-Y, et al. Maternal circulating leptin profile during pregnancy and gestational diabetes mellitus. Diabetes Res Clin Pract. 2020;161:108041. doi:10.1016/j.diabres.2020.108041
  • Peltokorpi A, Irina L, Liisa V, Risto K. Preconceptual leptin levels in gestational diabetes and hypertensive pregnancy. Hypertens Pregnancy. 2022;41(1):70–77. doi:10.1080/10641955.2022.2033763
  • Bawah AT, Seini MM, Abaka-Yawason A, Alidu H, Nanga S. Leptin, resistin and visfatin as useful predictors of gestational diabetes mellitus. Lipids Health Dis. 2019;18(1). doi:10.1186/s12944-019-1169-2
  • Florian AR, Cruciat G, Pop RM, Staicu A, Daniel M, Florin S. Predictive role of altered leptin, adiponectin and 3-carboxy-4-methyl-5-propyl-2-furanpropanoic acid secretion in gestational diabetes mellitus. Exp Ther Med. 2021;21(5). doi:10.3892/etm.2021.9951
  • Lappas M, Yee K, Fau - Permezel M, Rice GE. Release and regulation of leptin, resistin and adiponectin from human placenta, fetal membranes, and maternal adipose tissue and skeletal muscle from normal and gestational diabetes mellitus-complicated pregnancies. J Endocrinol. 2005;186(3):457–465. doi:10.1677/joe.1.06227
  • Yao Z, Zhang Y, Wu H. Regulation of C-reactive protein conformation in inflammation. Inflammat Res. 2019;68(10):815–823. doi:10.1007/s00011-019-01269-1
  • Jiang XC, Liang ZD, Chen DL, Jia JP, Hu JR, Hu L. Correlation of homocysteine, AHSG, CRP with insulin resistance, 25-(OH)2-VitD, blood lipids in gestational diabetes patients. Clin Lab. 2021. doi:10.7754/Clin.Lab.2020.200609
  • Alamolhoda SH, Yazdkhasti M, Namdari M, Zakariayi SJ, Mirabi P. Association between C-reactive protein and gestational diabetes: a prospective study. J Obstet Gynaecol. 2020;40(3):349–353. doi:10.1080/01443615.2019.1631767
  • Liu W, Huang Z, Tang S, Zhang Z, Yu Q, He J. Changes of serum sex hormone-binding globulin, homocysteine, and hypersensitive CRP levels during pregnancy and their relationship with gestational diabetes mellitus. Gynecol Obstet Invest. 2021;86(1–2):193–199. doi:10.1159/000515085
  • Yu N, Cui HA-O, Chen X, Chang Y. Changes of serum pentraxin-3 and hypersensitive CRP levels during pregnancy and their relationship with gestational diabetes mellitus. PLoS One. 2019;14(11):e0224739.
  • Amirian A, Rahnemaei FA, Abdi F. Role of C-reactive Protein(CRP) or high-sensitivity CRP in predicting gestational diabetes Mellitus:Systematic review. Diabetes Metabol Syndr Clin Res Rev. 2020;14(3):229–236. doi:10.1016/j.dsx.2020.02.004
  • Durnwald CA-O, Downes K, Leite R, Elovitz M, Parry S. Predicting persistent impaired glucose tolerance in patients with gestational diabetes: the role of high sensitivity CRP and adiponectin. Diabetes Metab Res Rev. 2018;34(2). doi:10.1002/dmrr.2958
  • Vecchié A, Bonaventura AA-O, Carbone FA-O, et al. C-reactive protein levels at the midpregnancy can predict gestational complications. Biomed Res Int. 2018;2018:1–8. doi:10.1155/2018/1070151
  • Mohammedi K, Bellili-Muñoz N, Driss F, et al. Manganese superoxide dismutase (SOD2) polymorphisms, plasma advanced oxidation protein products (AOPP) concentration and risk of kidney complications in subjects with type 1 diabetes. PLoS One. 2014;9(5):e96916. doi:10.1371/journal.pone.0096916
  • Shu JJ, Xiong HL, Yang J. Expression and significance of LCN-2 and AOPP in gestational diabetes mellitus complicated by preeclampsia. J Nanchang Univ. 2018;58(05):59–61. doi:10.13764/j.cnki.ncdm.2018.05.012
  • Walentowicz-Sadlecka MA-O, Domaracki PA-OX, Sadlecki PA-O, et al. Assessment of the SFlt-1 and sFlt-1/25(OH)D Ratio as a Diagnostic Tool in Gestational Hypertension (GH), Preeclampsia (PE), and Gestational Diabetes Mellitus (GDM). Disease Markers2019;2019;1875–8630.
  • Ghedini GC, Ronca R, Presta M, Giacomini A. Future applications of FGF/FGFR inhibitors in cancer. Expert Rev Anticancer Ther. 2018;18(9):861–872. doi:10.1080/14737140.2018.1491795
  • Xie Y, Su N, Yang J, et al. FGF/FGFR signaling in health and disease. Signal Transduct Targeted Ther. 2020;5(1):181.
  • Bonakdaran S, Khorasani ZM, Jafarzadeh F. Increased serum level of fgf21 in gestational diabetes mellitus. Acta Endocrinologica. 2017;13(3):278–281. doi:10.4183/aeb.2017.278
  • Wang Z, Yuan M, Xu C, Zhang Y, Ying C, Xiao X. FGF21 serum levels in the early second trimester are positively correlated with the risk of subsequent gestational diabetes mellitus: a propensity-matched nested case-control study. Front Endocrinol. 2021;12. doi:10.3389/fendo.2021.630287
  • Dekker Nitert M, Scholz-Romero K, Kubala MH, McIntyre HD, Callaway LK, Barrett HL. Placental fibroblast growth factor 21 is not altered in late-onset preeclampsia. Reprod Biol Endocrinol. 2015;13(1). doi:10.1186/s12958-015-0006-3
  • Acquarone E, Monacelli F, Borghi R, Nencioni A, Odetti P. Resistin: a reappraisal. Mech Ageing Dev. 2019;178:46–63.
  • Siddiqui K, George TP. Resistin role in development of gestational diabetes mellitus. Biomark Med. 2017;11(7):579–586. doi:10.2217/bmm-2017-0013
  • Xie Y, Zhou W, Tao XA-OX, Lv H, Cheng ZA-O. Early gestational blood markers to predict preeclampsia complicating gestational diabetes mellitus. Diabetes Metabol Syndr Obes. 2023;Volume 16:1493–1503. doi:10.2147/DMSO.S410912
  • Xue Y, Yang N, Ma L, Gu X, Jia K. Predictive value of the complement factors B and H for women with gestational diabetes mellitus who are at risk of preeclampsia. Pregnancy Hypertens. 2022;30:210–214. doi:10.1016/j.preghy.2022.10.010
  • Yang SY, Fan L, Yin YP. Analysis of high risk and prognostic factors of preeclampsia in pregnant women with gestational diabetes mellitus. Mater Child Health Care China. 2021;36(03):638–640. doi:10.19829/j.zgfybj.issn.1001-4411.2021.03.049